The achievement of a 3-month complete cytogenetic response to second-generation tyrosine Kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure

Elias Jabbour, Hagop Kantarjian, Hady Ghanem, Susan O'Brien, Alfonso Quintas-Cardama, Guillermo Garcia-Manero, Marylou Cardenas, Jorge Cortes

Research output: Contribution to journalArticle

18 Scopus citations

Fingerprint Dive into the research topics of 'The achievement of a 3-month complete cytogenetic response to second-generation tyrosine Kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure'. Together they form a unique fingerprint.

Medicine & Life Sciences